Swiss Biotech Report 2017
The Swiss Biotech Report 2017 has just been published. It illuminates the most important drivers of innovation and summarises issues and facts about the development of the Swiss biotech industry. Compiled by a group of representatives from public institutions – including the Federal Institute of Intellectual Property – and current enterprises, it appears annually. Press release (pdf, 124 KB)
Switzerland among European top nations in innovation to fight cancer
A study reveals that IP rights such as patents help Swiss SMEs and start-ups find investors
Conference on Intellectual Property & Sustainability at the University of Geneva
Symposium: "Best practices in the fight against counterfeiting & piracy – NFTs not your cup of tea? Well, they should: NFTs as a new way of fighting counterfeiting and piracy"